Injection site reactions to TNF-α blocking agents with positive skin tests

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 1, 2008, Pages 138-139

  Benucci, M ^a   Manfredi, M ^b   Demoly, P ^b   Campi, P ^b  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b NONE

Author keywords

Adalimumab; Drug eruptions; Etanercept; Skin tests; Tumor necrosis factor antagonists

Indexed keywords

ADALIMUMAB; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN E; METHOTREXATE; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EDEMA; ERYTHEMA; FEMALE; HUMAN; HYPERSENSITIVITY REACTION; INJECTION SITE REACTION; MALE; PRIORITY JOURNAL; PRURITUS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SKIN TEST;

AGED; ANTIBODIES, MONOCLONAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RISK ASSESSMENT; SAMPLING STUDIES; SKIN TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36649025481     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01536.x     Document Type: Article

References (6)

1. Pichler WJ, Campi P. Adverse side effects to biological agents. In : Pichler WJ, editor. Drug hypersensitivity. Basel : Karger, 2007 : 160 174.
2. Dore RK, Mathews S, Schechtman J, Surbeck W, Mandel D, Patel A et al. The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. Clin Exp Rheumatol 2007 25 : 40 46.
3. Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003 48 : 35 45.
4. Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin C, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. Arch Dermatol 2001 137 : 893 899.
5. Winfield H, Lain E, Horn T, Hoskyn J. Eosinophilic cellulitis like reaction to subcutaneous etanercept injection. Arch Dermatol 2006 142 : 218 220.
6. Bonifazi F, Jutel M, Bilò BM, Birnbaum J, Muller U. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005 60 : 1459 1470.